Low Toxicity in Inflammatory Bowel Disease Patients Treated With Abdominal and Pelvic Radiation Therapy

被引:24
|
作者
White, Evan C. [1 ]
Murphy, James D. [1 ]
Chang, Daniel T. [1 ]
Koong, Albert C. [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford Canc Inst, Stanford, CA 94305 USA
关键词
inflammatory bowel disease; toxicity; intensity-modulated radiation therapy (IMRT); RADIOTHERAPY; CANCER; SURGERY; HISTORY; TRIAL; RISK;
D O I
10.1097/COC.0000000000000010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective:To determine the short-term and long-term toxicity of abdominal and pelvic radiation therapy in a cohort of patients with inflammatory bowel disease (IBD). We hypothesize that with newer techniques, such as intensity-modulated radiation therapy (IMRT) and 3-dimensional conformal radiotherapy (3D-CRT), patients with IBD can safely undergo abdominal and pelvic radiation, with low risk for major acute or late toxicity.Materials and Methods:Nineteen consecutive patients with IBD (14 with ulcerative colitis, 5 with Crohn disease) who were treated with abdominal or pelvic external beam radiation therapy at Stanford University from 1997 to 2011 were identified. Fourteen patients were treated with IMRT and 5 were treated with 3D-CRT. Treated sites included prostate (n=8), gastric/esophageal (n=5), rectal/anal (n=3), and liver (n=3) tumors. Charts were reviewed and toxicity was graded according to the Common Terminology Criteria for Acute Events version 4.0. Median follow-up was 32.5 months. Fisher exact test was used to determine if any clinical and/or treatment factors were associated with toxicity outcomes.Results:Acute grade 3 toxicity occurred in 2 patients (11%). Late grade 3 toxicity occurred in 1 patient (6%). Acute grade 2 toxicity occurred in 28% of patients treated with IMRT versus 100% of patients treated with 3D-CRT (P=0.01). Acute grade 2 gastrointestinal toxicity was lower in patients treated with IMRT versus 3D-CRT (14% vs. 100%, respectively, P=0.002). Late grade 2 toxicity occurred in 21% of patients. Higher total dose (Gy) and biologically effective dose (Gy) were associated with increased rates of late grade 2 toxicity (P=0.02 and 0.03, respectively).Conclusions:These data suggest that select patients with IBD can safely undergo abdominal and pelvic radiation therapy. The use of IMRT was associated with decreased acute toxicity. Acute and late severe toxicity rates were low in this patient population with the use of modern radiation techniques.
引用
收藏
页码:564 / 569
页数:6
相关论文
共 50 条
  • [21] Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: Risks and benefits
    Bianca W. Chang
    Aryavarta M. S. Kumar
    Shlomo A. Koyfman
    Matthew Kalady
    Ian Lavery
    May Abdel-Wahab
    International Journal of Colorectal Disease, 2015, 30 : 403 - 408
  • [22] Radiation exposure in patients with inflammatory bowel disease
    Jorissen, Thibaud
    Fierens, Liselotte
    Bosmans, Hilde
    Verstockt, Bram
    Sabino, Joao
    Vermeire, Severine
    Vanbeckevoort, Dirk
    Ferrante, Marc
    JOURNAL OF CROHNS & COLITIS, 2025, 19 (01):
  • [23] Radiation exposure in patients with inflammatory bowel disease
    Jorissen, T.
    Fierens, L.
    Bosmans, H.
    Verstockt, B.
    Sabino, J.
    Vermeire, S.
    Vanbeckevoort, D.
    Ferrante, M.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I638 - I638
  • [24] Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: Risks and benefits
    Chang, Bianca W.
    Kumar, Aryavarta M. S.
    Koyfman, Shlomo A.
    Kalady, Matthew
    Lavery, Ian
    Abdel-Wahab, May
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2015, 30 (03) : 403 - 408
  • [25] Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease
    Lightner, Amy
    Raffals, Laura
    Mathis, Kellie
    Cima, Robert
    Tse, Chung Sang
    Pemberton, John
    Dozois, Eric
    Loftus, Edward V.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (02): : 185 - 190
  • [27] Toxicity and response to thiopurines in patients with inflammatory bowel disease
    Goldberg, Rimma
    Irving, Peter M.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2015, 9 (07) : 891 - 900
  • [28] Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease
    Skelly, MM
    Logan, RFA
    Jenkins, D
    Mahida, YR
    Hawkey, CJ
    INFLAMMATORY BOWEL DISEASES, 2002, 8 (02) : 93 - 97
  • [29] Microbiota and radiation-induced bowel toxicity: lessons from inflammatory bowel disease for the radiation oncologist
    Ferreira, Miguel R.
    Muls, Ann
    Dearnaley, David P.
    Andreyev, H. Jervoise N.
    LANCET ONCOLOGY, 2014, 15 (03): : E139 - E147
  • [30] Gastrointestinal Toxicity Following Proton and Photon Radiation for Prostate Cancer in Patients with Inflammatory Bowel Disease
    Wairiri, L. W.
    Liao, J. J.
    Chen, J.
    Weg, E. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E448 - E448